|4Nov 14, 4:34 PM ET

ALTOMARI ALFRED 4

4 · AGILE THERAPEUTICS INC · Filed Nov 14, 2022

Insider Transaction Report

Form 4
Period: 2022-11-09
ALTOMARI ALFRED
DirectorChief Executive Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2022-11-09+30,00030,000 total
    Exercise: $0.20Exp: 2032-11-08Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]This option was granted on November 9, 2022. 25% of the shares subject to the stock option vest on November 9, 2023, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on November 9, 2026.

Documents

1 file
  • 4
    tm2230300-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT